These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4032262)

  • 1. Predictive relationships in the water solubility of salts of a nonsteroidal anti-inflammatory drug.
    Anderson BD; Conradi RA
    J Pharm Sci; 1985 Aug; 74(8):815-20. PubMed ID: 4032262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supersolubilization and Amorphization of a Weakly Acidic Drug, Flurbiprofen, by applying Acid-Base supersolubilization (ABS) principle.
    Syed MI; Kandagatla HP; Avdeef A; Serajuddin ATM
    Int J Pharm; 2024 Sep; 663():124548. PubMed ID: 39098746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the counterion on the solubility and physicochemical properties of salts of carboxylic acid drugs.
    David SE; Timmins P; Conway BR
    Drug Dev Ind Pharm; 2012 Jan; 38(1):93-103. PubMed ID: 22118222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preformulation salt selection. Physical property comparisons of the tris(hydroxymethyl)aminomethane (THAM) salts of four analgesic/antiinflammatory agents with the sodium salts and the free acids.
    Gu L; Strickley RG
    Pharm Res; 1987 Jun; 4(3):255-7. PubMed ID: 3509292
    [No Abstract]   [Full Text] [Related]  

  • 5. Preparation and characterisation of a range of diclofenac salts.
    O'Connor KM; Corrigan OI
    Int J Pharm; 2001 Sep; 226(1-2):163-79. PubMed ID: 11532579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. pH-solubility profiles or organic carboxylic acids and their salts.
    Chowhan ZT
    J Pharm Sci; 1978 Sep; 67(9):1257-60. PubMed ID: 29115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of mixed counter ion on saturation solubility of esylate salt of a weak basic drug to formulate physically stable and non-hemolytic ready to use injectable solution.
    Dalwadi G; Sun Y; Wang L; Shick J; Hicks K; Lam S; Tuliani V; Patel K
    Int J Pharm; 2019 Dec; 572():118829. PubMed ID: 31715348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement and Accurate Interpretation of the Solubility of Pharmaceutical Salts.
    He Y; Ho C; Yang D; Chen J; Orton E
    J Pharm Sci; 2017 May; 106(5):1190-1196. PubMed ID: 28153596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salt Solubility and Disproportionation - Uses and Limitations of Equations for pH
    Avdeef A; Sugano K
    J Pharm Sci; 2022 Jan; 111(1):225-246. PubMed ID: 34863819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precaution on use of hydrochloride salts in pharmaceutical formulation.
    Miyazaki S; Oshiba M; Nadai T
    J Pharm Sci; 1981 Jun; 70(6):594-6. PubMed ID: 7252797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The preparation and evaluation of salt forms of linogliride with reduced solubilities as candidates for extended release.
    Chrzanowski FA; Ahmad K
    Drug Dev Ind Pharm; 2017 Mar; 43(3):421-431. PubMed ID: 27808569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solubilities and solid state properties of the sodium salts of drugs.
    Rubino JT
    J Pharm Sci; 1989 Jun; 78(6):485-9. PubMed ID: 2760824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salt formation to improve drug solubility.
    Serajuddin AT
    Adv Drug Deliv Rev; 2007 Jul; 59(7):603-16. PubMed ID: 17619064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. General treatment of pH-solubility profiles of weak acids and bases and the effects of different acids on the solubility of a weak base.
    Streng WH; Hsi SK; Helms PE; Tan HG
    J Pharm Sci; 1984 Dec; 73(12):1679-84. PubMed ID: 6527235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (STUDIES ON PHARMACEUTICAL PREPARATIONS OF OROTIC ACID. VII. WATER SOLUBLE PROPERTIES OF OROTIC ACID SALTS.).
    NAKATANI H
    Yakugaku Zasshi; 1964 Nov; 84():1057-61. PubMed ID: 14265125
    [No Abstract]   [Full Text] [Related]  

  • 16. Acidity constants in methanol/water mixtures of polycarboxylic acids used in drug salt preparations. Potentiometric determination of aqueous pKa values of quetiapine formulated as hemifumarate.
    Garrido G; Ràfols C; Bosch E
    Eur J Pharm Sci; 2006 May; 28(1-2):118-27. PubMed ID: 16488581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial salt screening procedures for manufacturing ibuprofen.
    Lee T; Wang YW
    Drug Dev Ind Pharm; 2009 May; 35(5):555-67. PubMed ID: 19005918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salt and cocrystals of sildenafil with dicarboxylic acids: solubility and pharmacokinetic advantage of the glutarate salt.
    Sanphui P; Tothadi S; Ganguly S; Desiraju GR
    Mol Pharm; 2013 Dec; 10(12):4687-97. PubMed ID: 24168322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In situ salt screening--a useful technique for discovery support and preformulation studies.
    Tong WQ; Whitesell G
    Pharm Dev Technol; 1998 May; 3(2):215-23. PubMed ID: 9653759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of pH and temperature on the solubility of a surface active carboxylic acid.
    Pandit NK; Strykowski JM
    J Pharm Sci; 1989 Sep; 78(9):767-70. PubMed ID: 2585273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.